MRI in ankylosing spondylitis

Area of Science:

• Rheumatology and Musculoskeletal Imaging

Background:

• Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints.
• Magnetic resonance imaging (MRI) has emerged as a key tool in evaluating AS.
• Recent advancements focus on validating MRI's role in clinical trials and patient management.

Purpose of the Study:

• To review recent multireader validation studies on MRI's reliability and discriminatory capabilities in AS.
• To assess the prognostic significance of MRI-detected lesions and MRI's predictive value for treatment response.
• To explore novel MRI-based technologies for diagnosing and managing AS.

Main Methods:

• Review of multireader validation exercises for MRI scoring systems in AS.
• Analysis of longitudinal data on MRI findings and their correlation with disease progression.
• Evaluation of clinical trial data assessing MRI's predictive capacity for treatment response.
• Inclusion of studies utilizing new MRI techniques in AS assessment.

Main Results:

• MRI scoring systems for sacroiliac joint and spinal inflammation are validated for clinical trials.
• Inflammatory lesions on MRI have prognostic significance for structural damage in AS.
• MRI aids in selecting patients likely to respond to anti-tumor necrosis factor agents.
• Advanced MRI techniques, like whole-body MRI, enhance diagnostic capabilities in AS.

Conclusions:

• MRI plays a crucial and expanding role in the diagnosis, prognosis, and therapeutic assessment of ankylosing spondylitis.
• Validated MRI metrics support its use in evaluating novel anti-inflammatory therapies for AS.
• MRI facilitates personalized treatment strategies by predicting patient response to specific therapies.